These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 9581733)

  • 1. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging.
    Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME
    J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis.
    Puig M; Ballester M; Matías-Guiu X; Bordes R; Carrió I; Kolodgie FD; Pons C; García A; Aymat MR; Marrugat J; Brossa V; Campreciós M; Padró JM; Caralps JM; Virmani R; Prat J; Narula J
    J Nucl Cardiol; 2000; 7(2):132-9. PubMed ID: 10796002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists.
    Winters GL; McManus BM
    J Heart Lung Transplant; 1996 Jul; 15(7):728-35. PubMed ID: 8820790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection.
    De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A
    J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation.
    Hesse B; Mortensen SA; Folke M; Brodersen AK; Aldershvile J; Pettersson G
    J Heart Lung Transplant; 1995; 14(1 Pt 1):23-31. PubMed ID: 7727472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis.
    Narula J; Khaw BA; Dec GW; Palacios IF; Newell JB; Southern JF; Fallon JT; Strauss HW; Haber E; Yasuda T
    J Nucl Cardiol; 1996; 3(5):371-81. PubMed ID: 8902668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection.
    Breuer M; Schütz A; Engelhardt M; Hammer C; Kemkes BM
    Angiology; 1999 Jul; 50(7):563-71. PubMed ID: 10431996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor scintigraphy predicts impending cardiac allograft rejection before endomyocardial biopsy.
    Aparici CM; Narula J; Puig M; Camprecios M; Martín JC; Tembl A; Flotats A; Estorch M; Catafau AM; Bernà L; Ballester M; Carrió I
    Eur J Nucl Med; 2000 Dec; 27(12):1754-9. PubMed ID: 11189936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications.
    Ballester M; Obrador D; Carrió I; Augé JM; Moya C; Pons-Lladó G; Caralps-Riera JM
    Circulation; 1990 Dec; 82(6):2100-7. PubMed ID: 2242534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with the application of monoclonal Indium-111 antimyosin scintigraphy in the diagnosis of rejection episodes following orthotopic heart transplantation].
    Hartmann A; Baum RP; Klepzig H; Huth A; Mondorf U; Herrmann G; Cieslinski G; Olbrich HG; Hör G; Krause E
    Z Kardiol; 1991 Jul; 80(7):454-8. PubMed ID: 1926991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience.
    Angelini A; Andersen CB; Bartoloni G; Black F; Bishop P; Doran H; Fedrigo M; Fries JW; Goddard M; Goebel H; Neil D; Leone O; Marzullo A; Ortmann M; Paraf F; Rotman S; Turhan N; Bruneval P; Frigo AC; Grigoletto F; Gasparetto A; Mencarelli R; Thiene G; Burke M
    J Heart Lung Transplant; 2011 Nov; 30(11):1214-20. PubMed ID: 21816625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection.
    Schuetz A; Fritsch S; Kemkes BM; Kugler C; Angermann C; Spes C; Anthuber M; Weiler A; Wenke K; Gokel JM
    J Heart Transplant; 1990; 9(6):654-61. PubMed ID: 2277304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive radioisotopic diagnosis of acute heart rejection.
    Latre JM; Arizón JM; Jiménez-Heffernan A; Anguita M; González FM; Rubio FL; Mesa MD; Montero A; Vallés F; Concha M
    J Heart Lung Transplant; 1992; 11(3 Pt 1):453-6; discussion 457. PubMed ID: 1610854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the usefulness of the antimyosin monoclonal antibody (AMA) uptake in the diagnosis of heart transplant (HT) rejection].
    Bello Arqués P; Almenar Bonet L; Martí Vidal JF; Pérez Velasco R; López Aznar D; Mateo Navarro A; Palencia Pérez M
    Rev Esp Med Nucl; 1999 Jun; 18(3):190-6. PubMed ID: 10431067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients.
    Bernstein D; Williams GE; Eisen H; Mital S; Wohlgemuth JG; Klingler TM; Fang KC; Deng MC; Kobashigawa J
    J Heart Lung Transplant; 2007 Dec; 26(12):1270-80. PubMed ID: 18096478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.
    Frist W; Yasuda T; Segall G; Khaw BA; Strauss HW; Gold H; Stinson E; Oyer P; Baldwin J; Billingham M
    Circulation; 1987 Nov; 76(5 Pt 2):V81-5. PubMed ID: 3311460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection.
    Carrió I; Berná L; Ballester M; Estorch M; Obrador D; Cladellas M; Abadal L; Ginjaume M
    J Nucl Med; 1988 Dec; 29(12):1893-900. PubMed ID: 3057128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimyosin antibodies in cardiac rejection.
    Schütz A; Breuer M; Kemkes BM
    Ann Thorac Surg; 1997 Feb; 63(2):578-81. PubMed ID: 9033354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.
    Marboe CC; Billingham M; Eisen H; Deng MC; Baron H; Mehra M; Hunt S; Wohlgemuth J; Mahmood I; Prentice J; Berry G
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S219-26. PubMed ID: 15993777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab.
    Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ
    J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.